Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	complement component C3b receptor activity	CR1 CR1L	3.89e-05	2	125	2	GO:0004877
GeneOntologyMolecularFunction	complement component C4b receptor activity	CR1 CR1L	3.89e-05	2	125	2	GO:0001861
GeneOntologyMolecularFunction	complement component C4b binding	CR1 CR1L	1.16e-04	3	125	2	GO:0001855
GeneOntologyMolecularFunction	extracellular matrix structural constituent	EMID1 LAMA1 SSPOP ENAM FGA LTBP2 MUC5AC	1.84e-04	188	125	7	GO:0005201
GeneOntologyMolecularFunction	opsonin binding	CR1 CR1L CD93	4.98e-04	25	125	3	GO:0001846
GeneOntologyMolecularFunction	ATPase inhibitor activity	FNIP2 TSC1	5.74e-04	6	125	2	GO:0042030
GeneOntologyMolecularFunction	complement binding	CR1 CR1L CD93	1.04e-03	32	125	3	GO:0001848
GeneOntologyMolecularFunction	opsonin receptor activity	CR1 CR1L	1.06e-03	8	125	2	GO:0001847
GeneOntologyBiologicalProcess	neuron development	SETX CECR2 SAMD4B CNTNAP1 LAMA1 LRTM1 APBB1 TRIOBP TSC1 TTC3 TFAP2A ANKRD27 PDLIM5 NRP2 ADORA2A PTPRD ATXN2 IGSF9 ROBO3 PARD3 CX3CL1 NANOS1 CRB2	1.84e-05	1463	124	23	GO:0048666
GeneOntologyBiologicalProcess	cell-cell adhesion	PKD1L1 LAG3 MCAM PCDHA11 AMBRA1 ITGA7 CR1 FCHO1 PDLIM5 CD93 ADORA2A PTPRD SYK FGA IGSF9 ROBO3 PARD3 CX3CL1 CRB2	2.31e-05	1077	124	19	GO:0098609
GeneOntologyBiologicalProcess	blood coagulation, common pathway	THBD FGA	3.59e-05	2	124	2	GO:0072377
GeneOntologyBiologicalProcess	tissue morphogenesis	MYLK CECR2 ESR2 LAMA1 TSC1 TFAP2A SYNE4 TFAP2C ZIC3 NRP2 MST1 CSF1 PARD3 CPLANE1 CRB2	4.49e-05	750	124	15	GO:0048729
MousePheno	abnormal polar trophectoderm morphology	LAMA1 CR1 CR1L TFAP2C THBD	1.02e-05	39	105	5	MP:0012056
MousePheno	abnormal ectoplacental cone morphology	LAMA1 CR1 CR1L TFAP2C THBD	1.02e-05	39	105	5	MP:0005032
MousePheno	endometrium hypoplasia	CYP27B1 CSF1	5.59e-05	2	105	2	MP:0009091
Domain	CD141	CD93 THBD	4.44e-05	2	125	2	IPR016316
Domain	MamL-1	MAML2 MAML3	1.33e-04	3	125	2	SM01275
Domain	Neuroggenic_mastermind-like_N	MAML2 MAML3	1.33e-04	3	125	2	IPR019082
Domain	MamL-1	MAML2 MAML3	1.33e-04	3	125	2	PF09596
Domain	FA58C	CNTNAP1 SSPOP NRP2	3.56e-04	21	125	3	SM00231
Domain	FA58C_3	CNTNAP1 SSPOP NRP2	3.56e-04	21	125	3	PS50022
Domain	FA58C_1	CNTNAP1 SSPOP NRP2	3.56e-04	21	125	3	PS01285
Domain	FA58C_2	CNTNAP1 SSPOP NRP2	3.56e-04	21	125	3	PS01286
Domain	Cupredoxin	PRPF8 PKHD1L1 HEPH	4.11e-04	22	125	3	IPR008972
Domain	EGF_2	CNTNAP1 LAMA1 SSPOP CD93 THBD ADAM33 LTBP2 CRB2	4.16e-04	265	125	8	PS01186
Domain	TF_AP2	TFAP2A TFAP2C	4.39e-04	5	125	2	IPR004979
Domain	TF_AP2_C	TFAP2A TFAP2C	4.39e-04	5	125	2	IPR013854
Domain	TF_AP-2	TFAP2A TFAP2C	4.39e-04	5	125	2	PF03299
Domain	F5_F8_type_C	CNTNAP1 SSPOP NRP2	5.34e-04	24	125	3	PF00754
Domain	FA58C	CNTNAP1 SSPOP NRP2	5.34e-04	24	125	3	IPR000421
Domain	GOLGA6L	GOLGA6L10 GOLGA6L9	6.55e-04	6	125	2	IPR026737
Domain	Hirudin/antistatin	CD300LD-AS1 MUC5AC	9.13e-04	7	125	2	IPR011061
Domain	EGF	CNTNAP1 LAMA1 CD93 THBD ADAM33 LTBP2 CRB2	1.04e-03	235	125	7	SM00181
Domain	EGF_3	CNTNAP1 SSPOP CD93 THBD ADAM33 LTBP2 CRB2	1.04e-03	235	125	7	PS50026
Domain	EGF-like_dom	CNTNAP1 LAMA1 CD93 THBD ADAM33 LTBP2 CRB2	1.45e-03	249	125	7	IPR000742
Domain	EGF	CNTNAP1 CD93 THBD LTBP2 CRB2	1.59e-03	126	125	5	PF00008
Domain	EGF_1	CNTNAP1 LAMA1 SSPOP THBD ADAM33 LTBP2 CRB2	1.66e-03	255	125	7	PS00022
Domain	EGF-like_CS	CNTNAP1 LAMA1 CD93 THBD ADAM33 LTBP2 CRB2	1.89e-03	261	125	7	IPR013032
Domain	LAM_G_DOMAIN	CNTNAP1 LAMA1 CRB2	2.08e-03	38	125	3	PS50025
Domain	Laminin_G_2	CNTNAP1 LAMA1 CRB2	2.41e-03	40	125	3	PF02210
Domain	C8	SSPOP MUC5AC	2.81e-03	12	125	2	PF08742
Domain	TIL	SSPOP MUC5AC	2.81e-03	12	125	2	PF01826
Domain	LamG	CNTNAP1 LAMA1 CRB2	3.17e-03	44	125	3	SM00282
Domain	Unchr_dom_Cys-rich	SSPOP MUC5AC	3.30e-03	13	125	2	IPR014853
Domain	C8	SSPOP MUC5AC	3.30e-03	13	125	2	SM00832
Domain	Znf_hrmn_rcpt	ESR2 NR4A1 NR1D1	3.60e-03	46	125	3	IPR001628
Domain	NUCLEAR_REC_DBD_2	ESR2 NR4A1 NR1D1	3.60e-03	46	125	3	PS51030
Domain	NUCLEAR_REC_DBD_1	ESR2 NR4A1 NR1D1	3.60e-03	46	125	3	PS00031
Domain	ZnF_C4	ESR2 NR4A1 NR1D1	3.60e-03	46	125	3	SM00399
Domain	zf-C4	ESR2 NR4A1 NR1D1	3.60e-03	46	125	3	PF00105
Domain	Nuclear_hrmn_rcpt	ESR2 NR4A1 NR1D1	3.60e-03	46	125	3	IPR001723
Domain	Galactose-bd-like	CNTNAP1 LAMA1 SSPOP NRP2	3.67e-03	94	125	4	IPR008979
Domain	-	ESR2 NR4A1 NR1D1	3.83e-03	47	125	3	1.10.565.10
Domain	VitD_rcpt	ESR2 NR1D1	3.84e-03	14	125	2	IPR000324
Domain	TIL_dom	SSPOP MUC5AC	3.84e-03	14	125	2	IPR002919
Domain	Nucl_hrmn_rcpt_lig-bd	ESR2 NR4A1 NR1D1	4.06e-03	48	125	3	IPR000536
Domain	HOLI	ESR2 NR4A1 NR1D1	4.06e-03	48	125	3	SM00430
Domain	Hormone_recep	ESR2 NR4A1 NR1D1	4.06e-03	48	125	3	PF00104
Domain	EGF_Ca-bd_CS	CD93 THBD LTBP2 CRB2	4.10e-03	97	125	4	IPR018097
Domain	EGF_CA	CD93 THBD LTBP2 CRB2	4.41e-03	99	125	4	PS01187
Domain	ASX_HYDROXYL	CD93 THBD LTBP2 CRB2	4.57e-03	100	125	4	PS00010
Domain	fn3	IL11RA MYLK PTPRD IGSF9 ROBO3	4.70e-03	162	125	5	PF00041
Domain	VWF_type-D	SSPOP MUC5AC	5.01e-03	16	125	2	IPR001846
Domain	VWFD	SSPOP MUC5AC	5.01e-03	16	125	2	PS51233
Domain	VWD	SSPOP MUC5AC	5.01e-03	16	125	2	SM00216
Domain	VWD	SSPOP MUC5AC	5.01e-03	16	125	2	PF00094
Domain	EGF-type_Asp/Asn_hydroxyl_site	CD93 THBD LTBP2 CRB2	5.62e-03	106	125	4	IPR000152
Domain	EMI	EMID1 SSPOP	5.66e-03	17	125	2	PS51041
Domain	GOLGA2L5	GOLGA6L10 GOLGA6L9	6.34e-03	18	125	2	PF15070
Domain	CTCK_1	SSPOP MUC5AC	6.34e-03	18	125	2	PS01185
Domain	Golgin_A	GOLGA6L10 GOLGA6L9	6.34e-03	18	125	2	IPR024858
Domain	-	ESR2 NR4A1 NR1D1	6.58e-03	57	125	3	3.30.50.10
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETX CECR2 TRIOBP AMBRA1 CHD8 ANKRD27 HEPH ZNF512B CCSER2 TNRC6A RAB11FIP5 IGSF9 MAML2	1.78e-07	529	136	13	14621295
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RADX APBB1 TAB3 KIAA1671 ATXN2 CCSER2 TNRC6A RAB11FIP5 PARD3	1.02e-06	263	136	9	34702444
Pubmed	Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast.	TFAP2A TFAP2C	1.52e-05	2	136	2	18042070
Pubmed	Functional identification of transcription control sequences of the mouse Crry gene.	CR1 CR1L	1.52e-05	2	136	2	8335915
Pubmed	Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells.	CR1 CR1L	1.52e-05	2	136	2	10779754
Pubmed	Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.	CR1 CR1L	1.52e-05	2	136	2	16444293
Pubmed	Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.	CR1 CR1L	1.52e-05	2	136	2	1730912
Pubmed	Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity.	ADORA2A CX3CL1	1.52e-05	2	136	2	23981568
Pubmed	Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.	CR1 CR1L	1.52e-05	2	136	2	19740350
Pubmed	A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.	LAG3 ADORA2A	1.52e-05	2	136	2	17909080
Pubmed	Activator protein-2 impairs the invasion of a human extravillous trophoblast cell line.	TFAP2A TFAP2C	1.52e-05	2	136	2	19443578
Pubmed	AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis.	TFAP2A TFAP2C	1.52e-05	2	136	2	8808408
Pubmed	The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.	TFAP2A TFAP2C	1.52e-05	2	136	2	30824562
Pubmed	Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family.	CR1 CR1L	1.52e-05	2	136	2	2952719
Pubmed	[Correlation of CD82 and hTERT expressions and HPV infection with penile cancer].	TERT CD82	1.52e-05	2	136	2	21961244
Pubmed	AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.	TFAP2A TFAP2C	1.52e-05	2	136	2	18443366
Pubmed	The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.	CR1 CR1L	1.52e-05	2	136	2	12767833
Pubmed	Functional genomics of AP-2α and AP-2γ in cancers: in silico study.	TFAP2A TFAP2C	1.52e-05	2	136	2	33213447
Pubmed	Regulation of complement activity via the alternative pathway in placentas of mouse spontaneous abortions.	CR1 CR1L	1.52e-05	2	136	2	20484840
Pubmed	Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.	TFAP2A TFAP2C	1.52e-05	2	136	2	20459791
Pubmed	Spleen tyrosine kinase induces MUC5AC expression in human airway epithelial cell.	SYK MUC5AC	1.52e-05	2	136	2	26980390
Pubmed	Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.	CR1 CR1L	1.52e-05	2	136	2	17674370
Pubmed	Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine).	SYK CX3CL1	1.52e-05	2	136	2	16148119
Pubmed	Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.	SYK CX3CL1	1.52e-05	2	136	2	21388954
Pubmed	Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.	CR1 CR1L	1.52e-05	2	136	2	11698469
Pubmed	Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones.	CR1 CR1L	1.52e-05	2	136	2	34709768
Pubmed	The murine complement regulator Crry: new insights into the immunobiology of complement regulation.	CR1 CR1L	1.52e-05	2	136	2	11915940
Pubmed	Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.	CR1 CR1L	1.52e-05	2	136	2	7691944
Pubmed	The murine complement receptor gene family. Analysis of mCRY gene products and their homology to human CR1.	CR1 CR1L	1.52e-05	2	136	2	2911011
Pubmed	Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.	CR1 CR1L	1.52e-05	2	136	2	12902517
Pubmed	Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.	CR1 CR1L	1.52e-05	2	136	2	17015675
Pubmed	Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.	CR1 CR1L	1.52e-05	2	136	2	23153828
Pubmed	Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice.	CR1 CR1L	1.52e-05	2	136	2	12973023
Pubmed	Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.	CR1 CR1L	1.52e-05	2	136	2	10586048
Pubmed	In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane.	CR1 CR1L	1.52e-05	2	136	2	16301687
Pubmed	Expression dynamics of Crry at the implantation sites in normal pregnancy and response against miscarriage induction.	CR1 CR1L	1.52e-05	2	136	2	36450590
Pubmed	A family of AP-2 proteins down-regulate manganese superoxide dismutase expression.	TFAP2A TFAP2C	1.52e-05	2	136	2	11278550
Pubmed	Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.	CR1 CR1L	1.52e-05	2	136	2	16301324
Pubmed	The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.	TNS2 SYK	1.52e-05	2	136	2	22019427
Pubmed	The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes.	CR1 CR1L	1.52e-05	2	136	2	2307848
Pubmed	Complement regulatory protein Crry/p65 costimulation expands natural treg cells with enhanced suppressive properties in proteoglycan-induced arthritis.	CR1 CR1L	1.52e-05	2	136	2	21380996
Pubmed	Cause-effect relation between hyperfibrinogenemia and vascular disease.	THBD FGA	1.52e-05	2	136	2	14615369
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MCAM TRIOBP TNS2 TSC1 PSMD13 TFAP2A TAB3 ZNF512B KIAA1671 PTPRD SLC4A1AP ATXN2 TNRC6A SLTM RAB11FIP5	1.63e-05	1049	136	15	27880917
Pubmed	Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.	IFFO1 ESR2 TNS2 TSC1 SAXO1 NR1D1 NRP2 ADORA2A CADPS2	3.10e-05	402	136	9	24722188
Pubmed	Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.	CHERP TSC1 NR4A1 ARHGEF11 KRBA1	3.18e-05	92	136	5	20368287
Pubmed	Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling.	MAML2 MAML3	4.54e-05	3	136	2	12386158
Pubmed	Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. An example of concerted (horizontal) evolution within a gene.	CR1 CR1L	4.54e-05	3	136	2	2295627
Pubmed	Sumoylation pathway is required to maintain the basal breast cancer subtype.	TFAP2A TFAP2C	4.54e-05	3	136	2	24835590
Pubmed	Regulation of Hoxa2 in cranial neural crest cells involves members of the AP-2 family.	TFAP2A TFAP2C	4.54e-05	3	136	2	10068641
Pubmed	Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77.	NR4A1 ADORA2A	4.54e-05	3	136	2	16673448
Pubmed	AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.	TFAP2A TFAP2C	4.54e-05	3	136	2	16636674
Pubmed	Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice.	CR1 CR1L	4.54e-05	3	136	2	11907125
Pubmed	Effect of ApoA4 on SERPINA3 mediated by nuclear receptors NR4A1 and NR1D1 in hepatocytes.	NR4A1 NR1D1	4.54e-05	3	136	2	28412351
Pubmed	An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.	CR1 CR1L	4.54e-05	3	136	2	20660348
Pubmed	Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice.	NR4A1 MST1	4.54e-05	3	136	2	36623453
Pubmed	[Hepatitis B virus X protein upregulates the expression of CD59 and Crry in mouse podocytes].	CR1 CR1L	4.54e-05	3	136	2	21215189
Pubmed	A critical role for murine complement regulator crry in fetomaternal tolerance.	CR1 CR1L	4.54e-05	3	136	2	10642554
Pubmed	Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.	TFAP2A TFAP2C	4.54e-05	3	136	2	23036739
Pubmed	Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma.	TFAP2A TFAP2C	4.54e-05	3	136	2	32462520
Pubmed	Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.	CR1 CR1L	4.54e-05	3	136	2	24850152
Pubmed	Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.	CR1 CR1L	4.54e-05	3	136	2	2528587
Pubmed	Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.	TFAP2A TFAP2C	4.54e-05	3	136	2	15548692
Pubmed	Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients.	MCAM THBD	4.54e-05	3	136	2	15897668
Pubmed	Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element.	TFAP2A TFAP2C	4.54e-05	3	136	2	12145340
Pubmed	Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.	CR1 CR1L	4.54e-05	3	136	2	7528766
Pubmed	A novel alternative spliced variant of the transcription factor AP2alpha is expressed in the murine ocular lens.	TFAP2A TFAP2C	4.54e-05	3	136	2	9758708
Pubmed	Developmental regulation and overexpression of the transcription factor AP-2, a potential regulator of the timing of Schwann cell generation.	TFAP2A TFAP2C	4.54e-05	3	136	2	11553286
Pubmed	Antithrombotic Effects of Nur77 and Nor1 Are Mediated Through Upregulating Thrombomodulin Expression in Endothelial Cells.	NR4A1 THBD	4.54e-05	3	136	2	26634653
Pubmed	t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.	MAML2 MAML3	4.54e-05	3	136	2	12539049
Pubmed	The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1.	CR1 CR1L	4.54e-05	3	136	2	2139460
Pubmed	AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.	TFAP2A TFAP2C	4.54e-05	3	136	2	16867219
Pubmed	Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma.	LAG3 ADORA2A	4.54e-05	3	136	2	34651389
Pubmed	Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.	TFAP2A TFAP2C	4.54e-05	3	136	2	12226108
Pubmed	Distinct acidic clusters and hydrophobic residues in the alternative splice domains X1 and X2 of alpha7 integrins define specificity for laminin isoforms.	LAMA1 ITGA7	4.54e-05	3	136	2	17618648
Pubmed	Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors.	TFAP2A TFAP2C	4.54e-05	3	136	2	8661133
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FASTKD5 FOCAD KRBA1 MAML2 MAML3	6.56e-05	107	136	5	11347906
Pubmed	p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics.	CR1 CR1L	9.06e-05	4	136	2	19124833
Pubmed	Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.	CR1 CR1L	9.06e-05	4	136	2	27165610
Pubmed	Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis.	CR1 CR1L	9.06e-05	4	136	2	24632830
Pubmed	Transcription factor AP-2gamma regulates murine adenosine deaminase gene expression during placental development.	TFAP2A TFAP2C	9.06e-05	4	136	2	9765260
Pubmed	The thrombomodulin-protein C system is essential for the maintenance of pregnancy.	THBD FGA	9.06e-05	4	136	2	12579195
Pubmed	Regulation of AP-2 and apoptosis in developing eye in a vitamin A-deficiency model.	TFAP2A TFAP2C	9.06e-05	4	136	2	12749383
Pubmed	DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.	CR1 CR1L	9.06e-05	4	136	2	16887189
Pubmed	Membrane protein Crry maintains homeostasis of the complement system.	CR1 CR1L	9.06e-05	4	136	2	18684964
Pubmed	Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients.	ESR2 MCAM	9.06e-05	4	136	2	28147335
Pubmed	Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.	CR1 CR1L	9.06e-05	4	136	2	16127466
Pubmed	The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.	TFAP2A TFAP2C	9.06e-05	4	136	2	21363924
Pubmed	The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps.	MCAM TERT	9.06e-05	4	136	2	21804459
Pubmed	Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy.	LAMA1 ITGA7	9.06e-05	4	136	2	19074617
Pubmed	Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.	CR1 CR1L	9.06e-05	4	136	2	12393518
Pubmed	Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.	CR1 CR1L	9.06e-05	4	136	2	20941861
Pubmed	Structural basis of binding of P-body-associated proteins GW182 and ataxin-2 by the Mlle domain of poly(A)-binding protein.	ATXN2 TNRC6A	9.06e-05	4	136	2	20181956
Pubmed	Distinct and separable activities of the endocytic clathrin-coat components Fcho1/2 and AP-2 in developmental patterning.	TFAP2A FCHO1	9.06e-05	4	136	2	22484487
Pubmed	The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation.	TFAP2A TFAP2C	9.06e-05	4	136	2	19115315
Pubmed	Cell death or survival promoted by alternative isoforms of ErbB4.	TFAP2A TFAP2C	9.06e-05	4	136	2	20943952
Pubmed	Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.	CR1 CR1L	9.06e-05	4	136	2	30217731
Pubmed	Formation and contraction of multicellular actomyosin cables facilitate lens placode invagination.	ARHGEF11 PARD3	9.06e-05	4	136	2	32113830
Pubmed	Telomere recombination requires the MUS81 endonuclease.	MUS81 TERT	9.06e-05	4	136	2	19363487
Pubmed	Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.	CR1 CR1L	9.06e-05	4	136	2	19281793
Pubmed	Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis.	TFAP2A TFAP2C	9.06e-05	4	136	2	12711551
GeneFamily	Ataxins\|Trinucleotide repeat containing	ATXN2 TNRC6A MAML3	1.60e-04	25	77	3	775
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	LAYN CD93 THBD	7.05e-04	41	77	3	1298
GeneFamily	Nuclear hormone receptors	ESR2 NR4A1 NR1D1	1.19e-03	49	77	3	71
GeneFamily	Immunoglobulin like domain containing	IL11RA LAG3 MCAM IGSF9 ROBO3	1.40e-03	193	77	5	594
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 AMBRA1 INO80D FOCAD TNRC6A MAML2 PARD3 CADPS2 MAML3	1.11e-08	199	136	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-MEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IL11RA LAYN MYLK ISM1 LAMA1 PLEKHA4 TFAP2C LTBP2	1.92e-07	200	136	8	53160551d558148d1d80ec87b90dd6be7d36e4c7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-MEC-MEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IL11RA LAYN MYLK ISM1 LAMA1 PLEKHA4 TFAP2C LTBP2	1.92e-07	200	136	8	af4d922659b6f9d446797f7a3922a211e22f88e4
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG LAG3 ZNF831 FCHO1 ADORA2A CD82 ZSCAN10	1.06e-06	173	136	7	82fa5ff6a00216a21a37fafeaf3e21e964c61d47
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG LAG3 ZNF831 FCHO1 ADORA2A CD82 ZSCAN10	1.06e-06	173	136	7	13f67f61edb734ff846da92d41e81ec4670a2b66
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CEL RADX CNTNAP1 THBD CSF1 ADAM33 ROBO3	1.19e-06	176	136	7	29b71369503719c74888cd356ceb6724cfdcabd9
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	DMXL2 SAP25 ABCB7 LAYN ANKRD27 FOCAD MAMSTR	1.54e-06	183	136	7	228092290dbb08785c4eda224e3ad03e99e10fab
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 AMBRA1 PTPRD MAML2 PARD3 CADPS2 MAML3	2.43e-06	196	136	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 AMBRA1 PTPRD MAML2 PARD3 CADPS2 MAML3	2.60e-06	198	136	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 LAMA1 LRTM1 SAXO1 PKHD1L1 TDRD6	9.88e-06	160	136	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 LAMA1 LRTM1 SAXO1 PKHD1L1 TDRD6	9.88e-06	160	136	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_D3\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	CAPG ISM1 NR4A1 ARHGEF11 CD82 MAML3	1.18e-05	165	136	6	a379fa981db51bec01adea7b1e55e133e15ec383
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	MYLK MCAM NR4A1 ITGA7 HEPH ROBO3	1.26e-05	167	136	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK ISM1 NRP2 ADAM33 LTBP2 MAML2	1.64e-05	175	136	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 CECR2 APBB1 KIAA1671 CD93 ROBO3	1.70e-05	176	136	6	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 CECR2 APBB1 KIAA1671 CD93 ROBO3	1.70e-05	176	136	6	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	COVID-19-Heart-Lymph_EC\|Heart / Disease (COVID-19 only), tissue and cell type	LAYN ZNF831 PKHD1L1 NRP2 KIAA1671 THBD	1.87e-05	179	136	6	411620201a860716a8773b92f50f7b94ef34a586
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNIP2 EMID1 LRTM1 NR1D1 STK11IP NRP2	1.87e-05	179	136	6	dd94ebe69ade6f51b94058abe066216f0de9feda
ToppCell	Mesenchymal_cells-Adipo-CAR\|Mesenchymal_cells / Lineage and Cell class	MYLK ISM1 CSF1 PTPRD LTBP2 CX3CL1	1.99e-05	181	136	6	1cfb03eb03a37b036b4eeacec69c9b8163af1ee4
ToppCell	droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESR2 MCAM TNS2 PKHD1L1 CADPS2 CX3CL1	2.25e-05	185	136	6	eeb6f55a6f79adf80247baa2c4b0df44553557ad
ToppCell	cellseq-Epithelial-Epithelial_Glandular-MEC-MEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK ISM1 LAMA1 PLEKHA4 TFAP2A TFAP2C	2.25e-05	185	136	6	76304829fcfb5934188933ca20d33bc8c8b0dc91
ToppCell	cellseq-Epithelial-Epithelial_Glandular-MEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK ISM1 LAMA1 PLEKHA4 TFAP2A TFAP2C	2.25e-05	185	136	6	0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL11RA ISM1 NRP2 CD82 PTPRD LTBP2	2.25e-05	185	136	6	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	(0)_MSCs\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MYLK ISM1 CSF1 PTPRD LTBP2 CX3CL1	2.32e-05	186	136	6	a832c1e0035bcd559722eccf262c145deb3494c7
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESR2 MCAM PKHD1L1 CD93 CADPS2 CX3CL1	2.32e-05	186	136	6	b80aaeebc03a318052076d2f02c123f5ddc5e73a
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESR2 MCAM PKHD1L1 CD93 CADPS2 CX3CL1	2.32e-05	186	136	6	8a8ed1502542d4895cba3fd5d534256206578716
ToppCell	(0)_MSCs-(00)_Lepr-MSC\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MYLK ISM1 CSF1 PTPRD LTBP2 CX3CL1	2.32e-05	186	136	6	f0d156167d7cc2cd8a76e5a364233e9f2170bc01
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DMXL2 SAP25 ABCB7 LAYN FOCAD MAMSTR	2.32e-05	186	136	6	74eb69a52090f9e2426a47e03a1c478ee0cfec18
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	MYLK ISM1 CSF1 PTPRD LTBP2 CX3CL1	2.32e-05	186	136	6	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CECR2 EMID1 PDLIM5 CD82 MAML2 PARD3	2.39e-05	187	136	6	daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	DMXL2 SAP25 ABCB7 LAYN FOCAD MAMSTR	2.39e-05	187	136	6	1eed2c1a05e80a7c8f639437c117afe0c18dfb0c
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CECR2 EMID1 PDLIM5 CD82 MAML2 PARD3	2.39e-05	187	136	6	5b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYLK ISM1 MCAM ITGA7 HEPH LTBP2	2.46e-05	188	136	6	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	ASK428-Endothelial-Lymphatic\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	LAYN PKHD1L1 HEPH NRP2 THBD RAB11FIP5	2.46e-05	188	136	6	c371bc340966cfe9205cbf4b62c6452f49f2559f
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA MYLK ISM1 NR1D1 NRP2 PTPRD	2.54e-05	189	136	6	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA MYLK ISM1 NR1D1 NRP2 PTPRD	2.54e-05	189	136	6	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	Globus_pallidus-Endothelial\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COPZ2 LAYN MYLK CAPG TNS2 THBD	2.54e-05	189	136	6	ad7dc9d25edd68fb624380a082c389fe7d640e7d
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA MYLK ISM1 NR1D1 NRP2 PTPRD	2.54e-05	189	136	6	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 LAMA1 TFAP2C HEPH MAML2 PARD3	2.61e-05	190	136	6	78cc6c28b31de041c24175a98f47da256ecc15a2
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK EMID1 MCAM ITGA7 NR1D1 IGSF9	2.61e-05	190	136	6	bfbdf16d488359d7935a419c4c1823288f39c183
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA MYLK ISM1 NR1D1 NRP2 PTPRD	2.61e-05	190	136	6	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK EMID1 MCAM ITGA7 NR1D1 IGSF9	2.61e-05	190	136	6	eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 LAMA1 TFAP2C HEPH MAML2 PARD3	2.61e-05	190	136	6	e67d9400467b438592690b23d681e6c2fb8f09fd
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA MYLK ISM1 NR1D1 NRP2 PTPRD	2.69e-05	191	136	6	44a9a6768084dafc641ad455b65862bfd4cc0cb9
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	PDLIM5 ZIC3 CD82 MAML2 CCDC140 CRB2	2.69e-05	191	136	6	06107849463a1ccb78a5ccd3ae31619ef6bedda3
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	FNIP2 IL11RA DMXL2 PSMD13 NR1D1 NRP2	2.69e-05	191	136	6	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYLK ISM1 LAG3 LRTM1 NR1D1 LTBP2	2.69e-05	191	136	6	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CAPG AFF3 NR4A1 CD82 SYK STAG3	2.69e-05	191	136	6	31169e01072e5fea364178264a35754b6cf2c93b
ToppCell	facs-Thymus-Epithelium-24m-Endothelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK TNS2 NRP2 KIAA1671 CD93 THBD	2.77e-05	192	136	6	39afea574725ce0c67afdd79facdb34f819a828d
ToppCell	facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK TNS2 NRP2 KIAA1671 CD93 THBD	2.77e-05	192	136	6	597db951b1fbc37db22134c3d27d3ec4ceaa85f7
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CAPG AFF3 PKHD1L1 ENAM CD82 SYK	2.77e-05	192	136	6	ab7420aeb22620d85c60b33cf372e5168e538cd4
ToppCell	facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK TNS2 NRP2 KIAA1671 CD93 THBD	2.77e-05	192	136	6	bc275a9eccb1c7a46fd58b15ca5acdd9f7495842
ToppCell	Hippocampus-Endothelial\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COPZ2 CAPG LAMA1 TNS2 TFAP2A THBD	2.77e-05	192	136	6	36deadab892d3e639a71f33697bb2d3cbbaa5372
ToppCell	droplet-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA MYLK ISM1 NR1D1 NRP2 PTPRD	2.77e-05	192	136	6	086b47f87283cd41139cd56686011f8b5821b0da
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYLK CECR2 NRP2 CD82 LTBP2 MAML3	2.77e-05	192	136	6	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	PLEKHA4 MCAM TNS2 NR4A1 TFAP2A NRP2	2.85e-05	193	136	6	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK EMID1 MCAM ITGA7 ADAM33 LTBP2	2.85e-05	193	136	6	800b0f5705fefcd3608e37801afae8a94474723e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	PLEKHA4 MCAM TNS2 NR4A1 TFAP2A NRP2	2.85e-05	193	136	6	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF3 CAPG AFF3 CR1 PKHD1L1 CD82	2.85e-05	193	136	6	de0213f2105b814f38ffbfd004ea7603230eed68
ToppCell	B_cells-Activate_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TCF3 CAPG AFF3 CR1 CD82 SYK	2.85e-05	193	136	6	b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155
ToppCell	COPD-Epithelial-Goblet\|Epithelial / Disease state, Lineage and Cell class	LAG3 CDC20B PDLIM5 CD82 CX3CL1 MUC5AC	2.94e-05	194	136	6	72a2e0cba171ab59aa176e91a59a54c562af0390
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL11RA MYLK NRP2 PTPRD MAML2 CADPS2	2.94e-05	194	136	6	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	normal_Lymph_Node-B_lymphocytes\|normal_Lymph_Node / Location, Cell class and cell subclass	AFF3 NR4A1 PKHD1L1 CD82 SYK STAG3	2.94e-05	194	136	6	cef40ae0bd5c07e73e726100113c46af05548690
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAYN MYLK ISM1 NRP2 FGA CRB2	2.94e-05	194	136	6	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK AFF3 ISM1 PDLIM5 HEPH NRP2	3.02e-05	195	136	6	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	facs-Mammary_Gland\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK EMID1 TMEM88B CSF1 LTBP2 CX3CL1	3.02e-05	195	136	6	21cfcb751e548591fc8724a8329c294da6012e0f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK AFF3 ISM1 PDLIM5 HEPH NRP2	3.02e-05	195	136	6	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	LAYN IFFO1 CNTNAP1 HEPH CSF1 CX3CL1	3.02e-05	195	136	6	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	ASK440-Endothelial\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	LAYN MCAM PKHD1L1 NRP2 CD93 THBD	3.02e-05	195	136	6	1cdaab17866a1e5170e0f6bfcc69134425fdd8df
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYLK MCAM ITGA7 HEPH LTBP2 CX3CL1	3.11e-05	196	136	6	a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK AFF3 ITGA7 PDLIM5 NRP2 ADAM33	3.11e-05	196	136	6	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK AFF3 ITGA7 PDLIM5 NRP2 LTBP2	3.11e-05	196	136	6	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAYN MYLK ISM1 NRP2 FGA CRB2	3.11e-05	196	136	6	023477a499a2c190f363cfdbc9d9c646733a6541
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK AFF3 ITGA7 PDLIM5 NRP2 LTBP2	3.11e-05	196	136	6	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYLK MCAM ITGA7 HEPH LTBP2 CX3CL1	3.11e-05	196	136	6	476812fc1422aca8010d771eff11fa6081f15a2d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAYN MYLK ISM1 NRP2 FGA CRB2	3.11e-05	196	136	6	3cb74f1a333a82cac2b459f2f1517e2acf22b5fd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK AFF3 ITGA7 PDLIM5 NRP2 ADAM33	3.11e-05	196	136	6	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK EMID1 TFAP2C TMEM88B LTBP2 CX3CL1	3.20e-05	197	136	6	f4dad4423384a2a25e064c849ffccf2811573be0
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	CAPG LAMA1 MCAM NR4A1 TFAP2C CRB2	3.20e-05	197	136	6	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AFF3 NR4A1 CR1 CD82 SYK STAG3	3.20e-05	197	136	6	85b5d284e7799335a1829a5d2d56bb0845f5cec5
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA COPZ2 AFF3 ISM1 NR1D1 LTBP2	3.20e-05	197	136	6	3fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	CAPG LAMA1 MCAM NR4A1 TFAP2C CRB2	3.20e-05	197	136	6	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK MCAM ITGA7 PDLIM5 CD82 CX3CL1	3.20e-05	197	136	6	71367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK MCAM ITGA7 PDLIM5 CD82 CX3CL1	3.20e-05	197	136	6	0f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCell	mLN-(2)_B_cell-(22)_B_cell_memory\|mLN / shred on region, Cell_type, and subtype	CAPG CR1 PKHD1L1 CD82 SYK STAG3	3.29e-05	198	136	6	4d189df1db5b41306e9653436d7d7e75ff5afa06
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AFF3 MCAM INO80D CD93 CADPS2 CX3CL1	3.29e-05	198	136	6	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	COPZ2 CEL ISM1 TTC3 HEPH LTBP2	3.29e-05	198	136	6	196257c4420ac801ed9fbb444f11718adb7560ae
ToppCell	ASK428-Endothelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	LAYN MCAM PKHD1L1 NRP2 THBD RAB11FIP5	3.29e-05	198	136	6	d69d0ff115298596173a4278897a65007a71f5df
ToppCell	mLN-B_cell-B_cell_memory\|mLN / Region, Cell class and subclass	CAPG CR1 PKHD1L1 CD82 SYK STAG3	3.29e-05	198	136	6	6dc155ee487abb1319a60a7a70e84c28c9851985
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FNIP2 DMXL2 PLEKHG2 NRP2 CD93 THBD	3.29e-05	198	136	6	76db943db8b5483754f38e4c6af7f5955cec420c
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMXL2 PLEKHG2 CR1 CD93 ADORA2A SYK	3.29e-05	198	136	6	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	AFF3 MCAM INO80D CD93 CADPS2 CX3CL1	3.39e-05	199	136	6	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DMXL2 CAPG CR1 CD93 THBD SYK	3.39e-05	199	136	6	9314eb9a89407738626a0384884454b5f9031ee7
ToppCell	mLN-B_cell\|mLN / Region, Cell class and subclass	CAPG AFF3 CR1 CD82 SYK STAG3	3.39e-05	199	136	6	99c7d157a1e819ff86c526ffd9b7036ed3514cae
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DMXL2 CR1 ENAM CD93 THBD SYK	3.39e-05	199	136	6	667b8b47a5b388506e3177b46747267fad8024f6
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AFF3 CR1 PKHD1L1 CD82 SYK STAG3	3.39e-05	199	136	6	1aa963ed5205d6d52262b1597a5d08707a95c3ca
ToppCell	mLN-(2)_B_cell\|mLN / shred on region, Cell_type, and subtype	CAPG AFF3 CR1 CD82 SYK STAG3	3.39e-05	199	136	6	9464c8c72a6b2e14a27b413cc1f5d64550212776
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DMXL2 CAPG CR1 CD93 THBD SYK	3.39e-05	199	136	6	dbf0bf09896c46155ae6fbd6307f097799e7e34e
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LAYN TRIOBP PKHD1L1 NRP2 THBD RAB11FIP5	3.48e-05	200	136	6	76e90231aa94afc12e618da8ae314c51644acab4
ToppCell	severe-HLA-DR-_S100A+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMXL2 CAPG CR1 CD93 THBD SYK	3.48e-05	200	136	6	a5eb50cbf3e94f0b3aa0fbef888989a11cffea37
Computational	Blood coagulation factors.	MST1 ADORA2A THBD FGA	6.90e-05	33	73	4	MODULE_131
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; HL60; HG-U133A	CHERP LRTM1 SHROOM2 FCHO1 CD93 FGA PARD3 STAG3 MAML3	2.55e-06	198	133	9	1391_UP
Disease	brain small vessel disease (is_implicated_in)	NR1D1 FGA	5.33e-05	3	125	2	DOID:0112313 (is_implicated_in)
Disease	lymphocyte activation gene 3 protein measurement	LAG3 ATXN2	5.33e-05	3	125	2	EFO_0020540
Disease	Autistic Disorder	MAGEL2 TSC1 CHD8 NRP2 RAB11FIP5 ROBO3 CADPS2	1.28e-04	261	125	7	C0004352
Disease	Ischemic stroke, factor VII measurement	ATXN2 FGA PARD3	2.50e-04	29	125	3	EFO_0004619, HP_0002140
Disease	Crohn's disease (is_marker_for)	ESR2 THBD FGA	2.50e-04	29	125	3	DOID:8778 (is_marker_for)
Disease	blood sedimentation	CR1 CR1L	3.69e-04	7	125	2	EFO_0004304
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP1 TSC1 CHD8 NRP2 CADPS2	4.85e-04	152	125	5	DOID:0060041 (implicated_via_orthology)
Disease	Kidney Diseases	NR4A1 TERT TFAP2A FGA	5.44e-04	88	125	4	C0022658
Disease	Thrombophilia	THBD FGA	6.29e-04	9	125	2	C0398623
Disease	Glaucoma	MYLK LTBP2	6.29e-04	9	125	2	C0017601
Disease	Situs ambiguous	PKD1L1 ZIC3	6.29e-04	9	125	2	C1167664
Disease	schizophrenia, intelligence, self reported educational attainment	FNIP2 ESR2 AFF3 AMBRA1 RAB11FIP5 MAML2 MAML3	7.01e-04	346	125	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	pulmonary fibrosis	TERT MUC5AC	9.55e-04	11	125	2	EFO_0009448
Disease	sleep disorder (implicated_via_orthology)	TFAP2A TFAP2C	9.55e-04	11	125	2	DOID:535 (implicated_via_orthology)
Disease	systemic lupus erythematosus (is_marker_for)	ESR2 TAB3 THBD	1.05e-03	47	125	3	DOID:9074 (is_marker_for)
Disease	Pulmonary Thromboembolisms	THBD FGA	1.14e-03	12	125	2	C0524702
Disease	Pulmonary Embolism	THBD FGA	1.14e-03	12	125	2	C0034065
Disease	visceral heterotaxy (is_implicated_in)	PKD1L1 ZIC3	1.14e-03	12	125	2	DOID:0050545 (is_implicated_in)
Disease	chronic kidney disease (implicated_via_orthology)	NR4A1 TERT	1.14e-03	12	125	2	DOID:784 (implicated_via_orthology)
Disease	Gastrointestinal Diseases	MYLK CHD8	1.14e-03	12	125	2	C0017178
Disease	Functional Gastrointestinal Disorders	MYLK CHD8	1.14e-03	12	125	2	C0559031
Disease	Cholera Infantum	MYLK CHD8	1.14e-03	12	125	2	C1565321
Disease	pulmonary embolism (biomarker_via_orthology)	FGA CX3CL1	1.14e-03	12	125	2	DOID:9477 (biomarker_via_orthology)
Disease	Malignant mesothelioma	MCAM HEPH CSF1 NANOS1	1.21e-03	109	125	4	C0345967
Disease	mean arterial pressure	TNS2 ZNF831 TERT PTPRD ATXN2 TNRC6A RAB11FIP5 SLC25A47	1.33e-03	499	125	8	EFO_0006340
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 TRIOBP	1.35e-03	13	125	2	C1846647
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	TERT ATXN2 PARD3	1.41e-03	52	125	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	anti-basement membrane glomerulonephritis (implicated_via_orthology)	CSF1 SYK	1.57e-03	14	125	2	DOID:4780 (implicated_via_orthology)
Disease	Situs ambiguus	PKD1L1 ZIC3	1.80e-03	15	125	2	C0266642
Disease	tumor necrosis factor measurement	APBB1 ATXN2	1.80e-03	15	125	2	EFO_0010834
Disease	Ischemic stroke, tissue plasminogen activator measurement	ATXN2 FGA	1.80e-03	15	125	2	EFO_0004791, HP_0002140
Disease	Mammary Carcinoma, Human	ESR2 NUDT17 TERT TFAP2A MST1 CSF1 PTPRD ADAM33	1.82e-03	525	125	8	C4704874
Disease	Mammary Neoplasms, Human	ESR2 NUDT17 TERT TFAP2A MST1 CSF1 PTPRD ADAM33	1.82e-03	525	125	8	C1257931
Disease	Mammary Neoplasms	ESR2 NUDT17 TERT TFAP2A MST1 CSF1 PTPRD ADAM33	1.87e-03	527	125	8	C1458155
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	ATXN2 FGA	2.05e-03	16	125	2	EFO_0004792, HP_0002140
Disease	preeclampsia, hypertension, pregnancy-induced	TNS2 ZNF831	2.05e-03	16	125	2	EFO_0000668, MONDO_0024664
Disease	Breast Carcinoma	ESR2 NUDT17 TERT TFAP2A MST1 CSF1 PTPRD ADAM33	2.12e-03	538	125	8	C0678222
Disease	thrombomodulin measurement	LAMA1 THBD	2.32e-03	17	125	2	EFO_0007774
Disease	dermatomyositis (is_marker_for)	THBD CX3CL1	2.32e-03	17	125	2	DOID:10223 (is_marker_for)
Disease	factor XI measurement, Ischemic stroke	ATXN2 FGA	2.32e-03	17	125	2	EFO_0004694, HP_0002140
Disease	pulmonary hypertension (is_marker_for)	TERT THBD CX3CL1	2.56e-03	64	125	3	DOID:6432 (is_marker_for)
Disease	cystitis (biomarker_via_orthology)	ESR2 CX3CL1	2.61e-03	18	125	2	DOID:1679 (biomarker_via_orthology)
Disease	frontal pole volume measurement	SYK NANOS1	2.61e-03	18	125	2	EFO_0010304
Disease	severe acute respiratory syndrome, COVID-19	CECR2 LRTM1 PTPRD LTBP2 MAML2 PARD3 CADPS2	3.01e-03	447	125	7	EFO_0000694, MONDO_0100096
Disease	skin pigmentation	SLTM MAML2 CADPS2	3.17e-03	69	125	3	EFO_0003784
Disease	glaucoma (is_marker_for)	HEPH MUC5AC	3.22e-03	20	125	2	DOID:1686 (is_marker_for)
Disease	portal hypertension (biomarker_via_orthology)	NR1D1 CX3CL1	3.89e-03	22	125	2	DOID:10762 (biomarker_via_orthology)
Disease	non-small cell lung carcinoma	LAMA1 SAXO1 TERT	4.01e-03	75	125	3	EFO_0003060
Disease	Alzheimer disease, educational attainment	FNIP2 ESR2 AFF3 CR1 MAML3	4.10e-03	247	125	5	EFO_0011015, MONDO_0004975
Disease	cognitive function measurement, self reported educational attainment	DMXL2 AFF3 TRIOBP TNRC6A RAB11FIP5 MAML3	4.12e-03	355	125	6	EFO_0004784, EFO_0008354

Protein segments in the cluster

Peptide	Gene	Start	Entry
PWSVLPGGQQRPHSE	AMER3	36	Q8N944
SRPQTKPWSPGSNGH	AFF3	946	P51826
TQQPGHLFWPPGSAL	CHD8	1731	Q9HCK8
HGISGWSPRIGDPNP	CNTNAP1	56	P78357
HQPAPTGSQQQAWPG	TFAP2C	91	Q92754
WANGSAPHPERRPNG	ADORA2A	346	P29274
RRTHSDTQATGWPPP	DNAH10OS	11	P0CZ25
DTQATGWPPPQRIGD	DNAH10OS	16	P0CZ25
APPTLGNNHQESPGW	BTBD6	101	Q96KE9
AWPRPHPGEGAAAAQ	COPZ2	6	Q9P299
APSGSPGVWREPSIH	CD93	536	Q9NPY3
ISVTSHPWDPGSPGQ	ARHGEF11	1241	O15085
HAQPQPQHPGWPGQR	TFAP2A	86	P05549
PQHPGWPGQRQSQES	TFAP2A	91	P05549
QRWGQPHGPVSSPLL	CD300LD-AS1	46	Q96MU5
CQQLWGPGSHPAPEA	ADAM33	526	Q9BZ11
GTTQWEPPGRASPSQ	APBB1	276	O00213
QAPSWGSPGRPAAHS	ASB16-AS1	26	Q495Z4
QVHPPSSLPWLGTGQ	DMXL2	2736	Q8TDJ6
QGWQGRSPQTSPSHP	FAM186B	176	Q8IYM0
ASWDQPGTPGREPTQ	AMBRA1	1231	Q9C0C7
ALENPQPHPGWQGTL	CEL	61	P19835
LAEPGSSPPWDHGNQ	CCDC140	11	Q96MF4
PQSFSDWQRPLHPQG	CECR2	1226	Q9BXF3
DWQRPLHPQGSPSGP	CECR2	1231	Q9BXF3
PGNRTQSGNHPEDWP	CD82	196	P27701
GAEPAAGPSRWLPTH	RAB11FIP5	6	Q9BXF6
FQPPQLSPWDGSFGH	NR4A1	146	P22736
GQPEAGPSHAGLDWP	RADX	6	Q6NSI4
GPSHAGLDWPNPERN	RADX	11	Q6NSI4
DWPERPGLTQTGPGH	ANKRD27	1001	Q96NW4
ARWLGEGPTPHPFAS	CYP27B1	431	O15528
PGPQSVPLQLSAHWQ	FCHO1	746	O14526
GSNHPGQPRQPNPDW	PCDHA11	791	Q9Y5I1
SPPSEGPRLGHLWQQ	ESPNL	786	Q6ZVH7
RPAQHPAWSTVEPAG	IL11RA	261	Q14626
DTRGVPQPSWGPEAQ	KRBA1	361	A5PL33
VSGNPPPEVIWLHNG	MYLK	646	Q15746
WPGSAHGVVLRPPEN	LRTM1	246	Q9HBL6
IPGESNRAPHPSSWE	FAM156A	141	Q8NDB6
SPIQVSGDWEHPNTP	MAGEL2	926	Q9UJ55
HPNTPRGLSGWEGPS	MAGEL2	936	Q9UJ55
RQTTSPNVLWPTPGH	ESR2	71	Q92731
WSHRGSEDGPRPQSN	KIAA1671	1131	Q9BY89
TGRHQPTGPWEQPSE	NFXL1	606	Q6ZNB6
HSNQTSNWSPLGPPS	MAML3	511	Q96JK9
SVSPNLWVPPGGHVE	NUDT17	116	P0C025
GAREHFASWPGTPAP	CRB2	1036	Q5IJ48
NGPLRTAGDSWHQPS	GPBP1L1	56	Q9HC44
GGRPQLPGSHPATWS	SYK	271	P43405
TIWPSPHQGNSPDLE	LAYN	276	Q6UX15
SDQRVVNGGVPWPSP	ATXN2	541	Q99700
DGLWTRNSPGSSQHP	LBHD1	11	Q9BQE6
APGPAHPQPFSSWND	NANOS1	31	Q8WY41
GQETRHGPSPSQWPA	NEK5	391	Q6P3R8
LWPRESPGTANGHSP	FAM214B	211	Q7L5A3
PQQSRLHGDDNGWTP	NRP2	306	O60462
QAGWTPQEHPGLSGE	GOLGA6L9	386	A6NEM1
QAGWTPQEHPGLSGE	GOLGA6L10	476	A6NI86
VTWQHQPDSGPPAAA	LAG3	61	P18627
NGPSSAHTGPPSSAW	MUC5AC	1346	P98088
PSWQRPNQGVPSTGR	PDLIM5	361	Q96HC4
SQNSGPGQPAVWHRL	PSMD13	11	Q9UNM6
PHTNHPNAWGASPAP	POU3F4	106	P49335
PTLVQGPGLSWVHPD	IFFO1	211	Q0D2I5
GGPPAQQSSSVRDPW	OVOL3	61	O00110
HQPTNWSALPSSAGP	MAML2	456	Q8IZL2
GSPPATTPHRWENQG	NR1D1	321	P20393
WQGSFQGIPRTVPPH	CCSER2	786	Q9H7U1
WNVSSTQHGGQDPPE	FASTKD5	31	Q7L8L6
GPVRPTGQDWNHTPQ	CSF1	371	P09603
PPSHDRPRNSEGWEQ	CHERP	696	Q8IWX8
TSDPHGNGVWSSPAP	CR1	1371	P17927
RKSFGQPQGSPWPHG	CPLANE1	3036	Q9H799
QPQGSPWPHGTATFT	CPLANE1	3041	Q9H799
TAAERHNPWPTGFPE	FNIP2	586	Q9P278
SEPHGNGVWSSPAPR	CR1L	526	Q2VPA4
QLGGHWPPTGITPLN	MT-CO3	111	P00414
QEGSGPALSPHPGLW	FAM25E	66	A8MYX2
RPQWGTQGDFTTTHP	CADPS2	406	Q86UW7
PASPGHSLWDSNNIP	LTBP2	516	Q14767
DSPGSGNARPNNPDW	FGA	396	P02671
PGPSLWEGTDSQQPH	MAMSTR	126	Q6ZN01
IWPHDPGASAQGQPL	CDC20B	381	Q86Y33
PRTHWGNLPVNLGDP	INO80D	886	Q53TQ3
PFPGSVQDPGLHVWR	CAPG	11	P40121
NNWGSPRREGPDAHP	ITGA7	1146	Q13683
PAGRNTWDHQEISPP	ENAM	561	Q9NRM1
FTETNNHWPQGPTGP	EMID1	281	Q96A84
GGHPGNSPWTVSLRN	MST1	486	P26927
NPPRGWDHTAPGHRT	ISM1	191	B1AKI9
AQTEAPHGPNSWGRI	PKD1L1	2036	Q8TDX9
PHGPNSWGRIPDAQE	PKD1L1	2041	Q8TDX9
AHQPGPNAPLSWVRA	CHID1	266	Q9BWS9
PWHQENGPAGPVPSF	FOCAD	1701	Q5VW36
QPWPNARPATQSGRH	PARD3	1181	Q8TEW0
IQWHPPVDTFGPLQG	PTPRD	841	P23468
GHPRPTISWNVNGTA	MCAM	456	P43121
SPEKWGPQGTHQSPS	NUTM2D	716	Q5VT03
SPGNARPWPQGAHGE	NUTM2F	171	A1L443
RPWPQGAHGEGSLAP	NUTM2F	176	A1L443
VAPATGHWNGQQAPP	SAP25	56	Q8TEE9
PWGPGQTGFVALPSH	STK11IP	51	Q8N1F8
APPGAVQGHWAREAP	THBD	226	P07204
PNGRAQTHTPGWVSD	TP53AIP1	36	Q9HCN2
AGSGEPPQHWPADAV	TDRD6	141	O60522
LGAPTQGPSPQGWHA	SSPOP	2096	A2VEC9
PHWSGPRGNVPVESQ	SAXO1	391	Q8IYX7
RGNEPAAHPPRWSTP	SYNE4	66	Q8N205
QSTPWQSSPQGPVPH	TAB3	246	Q8N5C8
GGGKPPRSPQHWSQE	PLEKHA4	306	Q9H4M7
PGYHQQPWRPGTVSS	LAMA1	306	P25391
QWNIPERSGPGPNDS	HEPH	861	Q9BQS7
TSGPRKEWHGPPSQG	SLTM	961	Q9NWH9
GGIFLWDPQPSSPQH	SETX	2551	Q7Z333
SPGSPLHARGQDSWP	SHROOM2	1036	Q13796
WLSPAGHSRPDVPGV	SLC25A47	206	Q6Q0C1
VWQSQEEPPGSQGPH	TRIOBP	1426	Q9H2D6
LVSVSGSGPQWRPHQ	ABCB7	31	O75027
GPQSGPRSHFSPWPR	LINC00612	16	Q8N6U2
GWIHTQPNESPQLSP	PRPF8	2176	Q6P2Q9
STSHNPGLPPNFNEW	ZIC3	451	O60481
DPASGGQSQHSWPCP	LINC02912	106	Q8N9X5
PPHQRAGPFSSRWET	TSC1	1051	Q92574
AWPAHPLGFGSRTPD	ZSCAN10	201	Q96SZ4
QRAPRGIPSWNDHGP	SPATA31A1	896	Q5TZJ5
PWPPRGLGSSTQHPN	SPATA12	31	Q7Z6I5
QHVSQAPGHPWGPVT	STAG3	1036	Q9UJ98
AGPGWQDKPPRENGH	SAMD4B	186	Q5PRF9
LHPSAELWSPPGQAG	TCF3	221	P15923
WPHPSRSPSAQEPRG	ROBO3	966	Q96MS0
LPQHRGWNPGDAPQT	ZNF276	271	Q8N554
SPSGRGWPSQNQELP	TTC3	2006	P53804
RGNHTTQDWALPEGP	PKHD1L1	3131	Q86WI1
QSLLWGDPAGTPSPH	IGSF9	816	Q9P2J2
HQASALTCPGWSGPP	TMEM88B	31	A6NKF7
HAGWNRSQPSPELAG	nan	81	Q3C1V9
PAPGGPEEQWQRAIH	ZNF512B	491	Q96KM6
QPLSWHGSSLDPQGP	PLEKHG2	1076	Q9H7P9
NSSGWNESVPRPPLH	TMC2	551	Q8TDI7
QGVPPGWPELALSSH	ZNF831	1141	Q5JPB2
HRPQGPAAWASTPIP	PVRIG	266	Q6DKI7
PERTPVGQGSWAHPG	TERT	246	O14746
NGSSSVNWPPEFRPG	TNRC6A	1601	Q8NDV7
SSPSDWPQERSPGGH	TNS2	981	Q63HR2
RRNPWCHPQAPGGSS	nan	41	Q6ZTC4
GPVPAHTDAFQDWGP	CX3CL1	266	P78423
HTLRSRPWGTPGNPE	MUS81	426	Q96NY9
WVPPEGQSGDGRTHL	SLC4A1AP	776	Q9BWU0